Dr. Sunita Ghimire Gautam Drives Nepal’s Biotech Revolution with Global Expertise
Raised in a rural part of Baglung, Dr. Sunita Ghimire Gautam returned to Nepal with a clear mission. She aims to build a self-reliant biotech sector using the skills she acquired abroad.
From humble beginnings to academic success
Gautam was born in Assam and grew up in Ward No. 9 of Galkot Municipality, Baglung. Her family had no formal education background, and her father served in the Indian Army.
She topped the district in the School Leaving Certificate examination in 2057 BS from Jana Jagriti Higher Secondary School. A scholarship later took her to Chitwan Science College. She earned a bachelor’s degree in Microbiology from Tri-Chandra College with top marks.
Training and research in Japan
Gautam moved to Japan after marriage and completed a master’s degree in Genetic Engineering at Saitama University. She then spent 11 years working at RIKEN, Japan’s largest research institute.
Her doctoral work focused on amyloid beta, a key protein linked to Alzheimer’s disease. During postdoctoral research, she created a gene-edited mouse model to study anxiety. Her projects covered molecular neuroscience, protein biochemistry, and advanced imaging tools.
Returning home and leading industry efforts
She and her husband decided to return to Nepal in 2018 to contribute locally. Gautam joined Kathmandu University through the E-GROW Fellowship.
She later moved to Shikhar Biotech and now serves as Research and Development Manager there. Shikhar Biotech is the only company in Nepal that develops antibodies for export to universities and research institutes.
Local solutions for pressing health problems
Gautam focused on snakebite, a neglected and deadly health challenge in Nepal. Imported anti-venom from India often fails against native species, such as pit vipers.
She led development of Nepal’s first locally produced anti-venom. The project received US$50,000 from the 2024 UNESCO-OWSD Early Career Fellowship. Final-stage dose-efficiency testing is underway.
Diagnostic kit manufacturing
During the COVID-19 pandemic, Gautam and colleagues formed Novala Biotech. The company produces locally made diagnostic kits.
- Pregnancy and ovulation tests
- Syphilis and HIV/AIDS kits
- Dengue, hepatitis, and COVID-19 diagnostics
The team developed and launched these kits in about a year. Their work aimed to reduce dependence on imports and strengthen local capacity.
Policy barriers and a call for support
Despite technical progress, regulatory hurdles persist. The Department of Drug Administration has not provided formal approval for many products.
Research continued under ethical clearance from the Nepal Health Research Council. But lack of clear policy limits market access and scale-up.
Gautam says regulators cite policy gaps and scarce human resources. She urges tax subsidies for raw materials and timely, supportive rules.
Vision for Nepal’s biotech future
Gautam believes policy reform can unlock broad growth. She sees potential for vaccine manufacturing and world-class cancer research in Nepal.
Dr. Sunita Ghimire Gautam brings global expertise to spur a biotech revolution in Nepal. Filmogaz.com reports her work as a model for turning international training into local innovation.
